Bharat Biotech, University of Sydney ink pact for vaccine research collaboration
Vaccines major Bharat Biotech International Ltd on Tuesday said it has entered into a collaboration with the University of Sydney Infectious Diseases Institute to advance vaccine research initiatives, strengthen academic-industry partnerships and augment global efforts to combat infectious diseases.
Vaccines major Bharat Biotech International Ltd on Tuesday said it has entered into a collaboration with the University of Sydney Infectious Diseases Institute to advance vaccine research initiatives, strengthen academic-industry partnerships and augment global efforts to combat infectious diseases.
The company has signed a Memorandum of Understanding (MoU) with the University of Sydney Infectious Diseases Institute (Sydney ID) for the collaboration that aims to build strong sectoral and cross-organisational collaborations to design novel methodologies to tackle future epidemics and infectious diseases, Bharat Biotech said in a statement.
Furthermore, the collaboration will also leverage academia-industry strengths for advancing the science of vaccines and biotherapeutics, it added.
"This agreement reflects our ethos to facilitate collaborative research, foster innovation, and further advance the science vaccine technology," Bharat Biotech Executive Chairman Krishna Ella said.
The collaboration will "leverage the prowess of education, research capabilities to help build a healthier universe and improve people's lives by developing safer vaccine platforms", he said, adding, "most importantly, (it will help) build the talent of young scientists with a passion to innovate".
Sydney ID Deputy Director Professor Jamie Triccas said, "The reputational and societal impacts of developing novel vaccines to eradicate human and animal diseases that are safe, affordable, and effective cannot be overstated. Together with Bharat Biotech International Ltd, we aim to make a lasting impact on global health." Bharat Biotech had played a key role in the combat against COVID-19 with its indigenously developed COVAXIN.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Senior Citizen Latest FD Rates: Know what major banks like SBI, PNB, Canara Bank, HDFC Bank, ICICI Bank are providing on fixed deposits
Gratuity Calculator: Rs 38,000 as last-drawn basic salary, 5 years and 5 months of service; what will be gratuity amount?
Retirement Planning: In how many years your Rs 25K monthly SIP investment will grow to Rs 8.8 cr | See calculations
Top 5 Small Cap Mutual Funds with best SIP returns in 1 year: See how Rs 25,000 monthly investment has grown in each scheme
Top 7 SBI Mutual Funds With Best SIP Returns in 1 Year: Rs 25,000 monthly SIP investment in No.1 fund has jumped to Rs 3,58,404
Top 7 Mid Cap Mutual Funds With up to 41% SIP Returns in 5 Years: No 1 fund has converted Rs 15,000 monthly investment into Rs 23,84,990
SBI 5-Year FD vs MIS: Which can offer higher returns on a Rs 2,00,000 investment over 5 years? See calculations
02:35 PM IST